إعلان مُمول
Blood-Based Biomarker for Parkinson’s Disease Market to Reach USD 2.71 Billion by 2034, Driven by Advances in Early Detection and Precision Medicine
Market Overview The global blood-based biomarker for Parkinson’s disease market is poised for unprecedented growth in the coming decade. Valued at USD 486.33 million in 2024, the market is projected to surge to USD 2,711.91 million by 2034, expanding at a remarkable compound annual growth rate (CAGR) of 18.8% during the forecast period (2025–2034). Blood-based biomarkers have...
0 التعليقات 0 المشاركات 23 مشاهدة
إعلان مُمول
إعلان مُمول